Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DxPx is an active healthcare-focused partnering and conference business centered on diagnostics, digital health, precision medicine, and life science tools rather than therapeutics development. The organization operates international industry and investor partnering events, including DxPx Europe and DxPx U.S., designed to facilitate licensing, financing, co-development, and M&A discussions. It also appears to operate adjacent activities under the DxPx Capital brand, including an angel investor network and startup support ecosystem. The business serves founders, investors, corporate business development teams, and strategic partners across health technology and life science tools. DxPx is best characterized as a commercial healthtech ecosystem and conference platform rather than a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DxPx.